ArticlePalliative medicine reports

Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer.

Satoru Miwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.